Electromed, Inc. $ELMD Stock Holdings Boosted by Hunter Associates Investment Management LLC

Hunter Associates Investment Management LLC grew its position in shares of Electromed, Inc. (NYSE:ELMDFree Report) by 25.1% during the 1st quarter, Holdings Channel reports. The firm owned 150,800 shares of the company’s stock after purchasing an additional 30,250 shares during the period. Hunter Associates Investment Management LLC’s holdings in Electromed were worth $3,529,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of ELMD. Millennium Management LLC lifted its holdings in shares of Electromed by 362.7% in the first quarter. Millennium Management LLC now owns 194,519 shares of the company’s stock valued at $4,641,000 after buying an additional 152,480 shares during the period. NewEdge Advisors LLC boosted its stake in Electromed by 20.1% during the first quarter. NewEdge Advisors LLC now owns 17,952 shares of the company’s stock valued at $428,000 after buying an additional 3,001 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in Electromed by 9.0% during the first quarter. Goldman Sachs Group Inc. now owns 32,281 shares of the company’s stock worth $770,000 after acquiring an additional 2,672 shares during the period. Jane Street Group LLC grew its holdings in Electromed by 136.3% during the first quarter. Jane Street Group LLC now owns 56,263 shares of the company’s stock worth $1,342,000 after acquiring an additional 32,456 shares during the period. Finally, Geode Capital Management LLC raised its position in Electromed by 128.3% in the second quarter. Geode Capital Management LLC now owns 155,540 shares of the company’s stock worth $3,421,000 after acquiring an additional 87,401 shares in the last quarter. Institutional investors own 40.82% of the company’s stock.

Insider Transactions at Electromed

In related news, CFO Bradley M. Nagel sold 11,801 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $36.35, for a total value of $428,966.35. Following the completion of the transaction, the chief financial officer owned 19,638 shares in the company, valued at $713,841.30. This trade represents a 37.54% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kathleen Skarvan sold 40,000 shares of Electromed stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $35.48, for a total value of $1,419,200.00. Following the completion of the transaction, the director directly owned 35,622 shares in the company, valued at $1,263,868.56. This represents a 52.89% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 61,501 shares of company stock valued at $2,202,216 over the last three months. Company insiders own 10.50% of the company’s stock.

Wall Street Analysts Forecast Growth

ELMD has been the subject of a number of research analyst reports. Zacks Research raised shares of Electromed from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. B. Riley Financial lifted their price objective on shares of Electromed from $38.00 to $40.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. One research analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the company’s stock. Based on data from MarketBeat, Electromed has a consensus rating of “Buy” and an average price target of $37.50.

View Our Latest Report on ELMD

Electromed Stock Performance

Shares of NYSE:ELMD opened at $45.43 on Friday. The company has a market capitalization of $376.16 million, a PE ratio of 60.57 and a beta of 0.50. The stock has a fifty day moving average of $35.55 and a 200-day moving average of $29.50. Electromed, Inc. has a one year low of $17.73 and a one year high of $45.49.

About Electromed

(Free Report)

Electromed Inc (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients.

The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components.

Read More

Want to see what other hedge funds are holding ELMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Electromed, Inc. (NYSE:ELMDFree Report).

Institutional Ownership by Quarter for Electromed (NYSE:ELMD)

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.